explained a potential mechanism in their study: SLC39A4 mediates pancreatic cancer cell growth by upregulating the expression of neuropilin‐1 (NRP‐1), vascular endothelial growth factor (VEGF), and matrix metalloproteases (MMPs) in cell lines and xenografts.32 Here, VEGFA is linked to pancreatic neoplasm.